Skip to main content

Table 1 Baseline Patient Characteristics

From: Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

Characteristic

Total (N = 40)

Age

 Median

65 years

 Range

37 to77 years

Gender

 Male

34 (85 %)

 Female

6 (15 %)

Performance Status

 ECOG 0

19 patients (48 %)

 ECOG 1

21 patients (52 %)

Pathology

 Adenocarcinoma

34 patients (85 %)

 Squamous carcinoma

6 patients (15 %)

Stage (AJCC 5th edition)

 Stage IIA

12 patients (30 %)

 Stage IIB

8 patients (20 %)

 Stage III

9 patients (22.5 %)

 Stage IVA

11 patients (27.5 %)

Tumor Location

 Middle Esophagus

7 patients (17.5 %)

 Lower Esophagus

23 patients (57.5 %)

 Gastroesophageal Junction

10 patients (25 %)

Dysphagia (Grade ≥1)

34 patients (85 %)

Greater than 10 % weight loss

10 patients (25 %)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us